|
|
||||||||
Clinical Chemistry, Vol 41, 1248-1255, Copyright © 1995 by American Association for Clinical Chemistry
EK Shultz
Program in Medical Information Science, Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA.
The evolution of test performance analysis should include the long-term costs and benefits associated with testing. Evolutionary laboratory techniques to achieve this include introduction of a new methodological technique, a multivariate extension to a current analytical technique, receiver-operating characteristic (ROC) curve analysis (MultiROC analysis). This extension to ROC methodology allows the comparison of composite test rules in a format similar to that of ROC curves. Statistical properties, guidelines for use, and a detailed example are described. MultiROC is used in the outcomes analysis of the value of screening for prostate cancer. The effect of age and different test decision thresholds are examined in an extension of a previously published outcomes analysis. The results indicate that the variations in test performances caused by these components are important in assigning a final cost:benefit ratio of screening for prostate cancer.
The following articles in journals at HighWire Press have cited this article:
![]() |
A. Tsigkou, D. Marrelli, F. M. Reis, S. Luisi, A. L. Silva-Filho, F. Roviello, S. A. Triginelli, and F. Petraglia Total Inhibin Is a Potential Serum Marker for Epithelial Ovarian Cancer J. Clin. Endocrinol. Metab., July 1, 2007; 92(7): 2526 - 2531. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Vasan Biomarkers of Cardiovascular Disease: Molecular Basis and Practical Considerations Circulation, May 16, 2006; 113(19): 2335 - 2362. [Full Text] [PDF] |
||||
![]() |
V. A. DeBari Computation of decision levels from differentiated logistic regression probability curves. Ann. Clin. Lab. Sci., March 1, 2006; 36(2): 194 - 200. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Henderson A Triptych of Statistics Clin. Chem., November 1, 2003; 49(11): 1959 - 1962. [Full Text] [PDF] |
||||
![]() |
K. Stoeber, R. Swinn, A. T. Prevost, P. de Clive-Lowe, I. Halsall, S. M. Dilworth, J. Marr, W. H. Turner, N. Bullock, A. Doble, et al. Diagnosis of Genito-Urinary Tract Cancer by Detection of Minichromosome Maintenance 5 Protein in Urine Sediments J Natl Cancer Inst, July 17, 2002; 94(14): 1071 - 1079. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Robertson, T. Stephenson, E. Pruysers, P. McCloud, A. Tsigos, N. Groome, P. Mamers, and H. G. Burger Characterization of Inhibin Forms and Their Measurement by an Inhibin {alpha}-Subunit ELISA in Serum from Postmenopausal Women with Ovarian Cancer J. Clin. Endocrinol. Metab., February 1, 2002; 87(2): 816 - 824. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Brathen, K. S Bjerve, E. Brodtkorb, and G. Bovim Validity of carbohydrate deficient transferrin and other markers as diagnostic aids in the detection of alcohol related seizures J. Neurol. Neurosurg. Psychiatry, March 1, 2000; 68(3): 342 - 348. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Robertson, N. Cahir, H. G. Burger, P. Mamers, P. I. McCloud, K. Pettersson, and M. McGuckin Combined Inhibin and CA125 Assays in the Detection of Ovarian Cancer Clin. Chem., May 1, 1999; 45(5): 651 - 658. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |